Physiomics to collaborate with the University of Oxford and the Oxford University Hospitals NHS trust on its Virtual Tumour Clinical research program
Physiomics is pleased to announce that it has signed a collaboration agreement with the University of Oxford and the Oxford University Hospitals NHS trust to support the development of Physiomics’ flagship Virtual Tumour Clinical technology.
Virtual Tumour Clinical is used to predict optimal clinical regimens for cancer trials. Physiomics has been seeking academic and industrial partners to help calibrate the model with key data obtained from such trials. This collaboration is the second such deal to be announced by Physiomics.